Group items tagged

The FTSE 100 is called to open lower this morning following the losses on Wall Street on Friday and in Asia overnight

Leading tech and social media names down on no news, Caterpillar propping up DJIA. - Troubled ICBC vehicle China Credit Trust saved by unnamed investor

If there is one area guaranteed to confuse many traders and lead to multiple opinions on the most appropriate approach, it is the subject of stop losses. The science and the art of placing stops is featured extensively in many trading books and guides, but the bottom line is that there is no right or wrong answer, simply the fact that stop losses must be used to limit potential downside exposure when trading. Traders should also be careful not to confuse stop losses with buy stops, which trigger an opening position rather than closing the trade. It is very important not to package together the placing of stops with money management, as the two represent different strands of trading. Simply put, stops are there to protect profits and limit the potential downside at any time once a trade has been opened, and are part of an exit strategy for trades that are already open. Money management covers position sizing or amounts to be risked within each trade of a portfolio.

good stuff http://mcx-silver-gold-tips.blogspot.in/2015/07/share-market-tips-gold-recovers-its.html

Wall Street is wavering between gains and losses today as the market is searching for a bottom, but investors are also taking profits and expecting to get back in at lower prices.

Wall Street is trading higher today as hope that the ECB may be getting a firmer handle on the financial crisis. In the U.S., Congress is gridlocked once more on spending.

News that European authorities are devising a plan to shore up big banks threatened by the region's debt crisis helped ignite a strong rebound in the substantially oversold Hong Kong market.

Big week for economic reports. Clue to recession or no recession! Look for sell off at open, but odds favor traders' rally starting after 10:45.

Crude oil reached its lowest levels in over a year in early morning trading but you would never know it from observing the late day rally from oil and gas stocks. Shares climbed on reports of more hope in the Greek debt dispute.

European markets fell sharply Tuesday after Eurozone finance ministers said last night that they will wait until later in October than previously thought to decide whether to extend more aid to Greece.

The Italian Parliament definitely cleared on Wednesday a 54-billion-euro emergency budget plan aimed at balancing public finances by 2013 to shield the country from the risk of a debt crisis.

Financial stocks were mixed on Friday with the major banks sliding on European debt woes and credit companies ticking higher on news of consumer confidence that outshined expectations.

Faiure of European finance ministers to tackle the region's debt crisis was one big factor, along with a rise in Hong Kong mortgage rates and a drop on Mainland markets.

The market looked to continue lower yesterday until the last hour, when an EU bank aid program was reported. European markets shrugged off Italy's three-notch downgrade and followed the U.S higher.

Remarks by the German finance minister hurt investors' confidence Europe would soon solve its debt crisis, triggering a sell-off in Hong Kong and other global markets.

Not only do companies have the potential to achieve what Novavax was able to under the right circumstances, but the industry is also full of big mergers and acquisitions. Early-stage companies develop clinical trial pipelines. Larger companies may then target these smaller firms as buyout candidates. For instance, Merck (NYSE: MRK) bought cancer drug research company VelosBio Inc. from Pappas Capital and other investors for $2.75 billion. Gilead Sciences (NASDAQ: GILD) picked up Immunomedics for $21 billion to gain access to a breast cancer treatment, Trodelvy. The list goes on. In this article, we'll look at a few current and former biotech penny stocks that have continued demonstrating strength in the stock market in 2021.

This article discusses a handful of penny stocks with exposure to potential Alzheimer's disease treatments. The bullish sympathy trend has come to light following late-breaking news on Tuesday that Biogen (NASDAQ: BIIB) and Eisai Co.'s experimental Alzheimer's drug significantly slowed the progression of the disease in a large study. The 18-month, Phase 3 study of 1,800 patients tested the treatment on early-stage Alzheimer's patients. 4 more Alzheimer's stocks to watch